Clinical development of intramuscular electroporation: Providing a "boost" for DNA vaccines

15Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The development of effective vaccines has helped to eradicate or control the spread of numerous infectious diseases. However, there are many more diseases that have proved more difficult to eliminate using conventional vaccines. The recent innovation of DNA vaccines may provide a "boost" to the development efforts. While the early efforts of DNA vaccines in the clinic were disappointing, the use of in vivo electroporation has helped to provide some basis for optimism. Now, there are several ongoing clinical studies of vaccines against such diseases as malaria, HIV, hepatitis C, and even various types of cancer. This review will highlight three recently published clinical studies using intramuscular DNA administration with electroporation. © 2014 Springer Science+Business Media New York.

Cite

CITATION STYLE

APA

Khan, A. S., Broderick, K. E., & Sardesai, N. Y. (2014). Clinical development of intramuscular electroporation: Providing a “boost” for DNA vaccines. Methods in Molecular Biology, 1121, 279–289. https://doi.org/10.1007/978-1-4614-9632-8_25

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free